14 December 2020: Pfizer is targeting to supply 1.3 billion doses of the vaccine in 2021, whereas Moderna is targeting somewhere between 500 million to 1 billion.

This could earn Pfizer unto $19 billion and Moderna upto $13.2 billion in revenue, which would result in them raking in $32 billion in combined revenues from their COVID-19 vaccine in 2021 alone.

Pfizer being the hare, wants to take a jump start and is already aiming to supply around 50 million doses of the vaccine by the end of 2020, which could help them generate around $975 million in revenues from its vaccine this year alone. Pfizer's shot has become the first COVID-19 vaccine to be authorized for emergency use in the West.

While UK was the first country to administer the vaccine outside the clinical trial, US and Canada are all set to roll out the vaccines to the general public this week.

If we add revenues generated in 2022 and 2023, Pfizer is expected to rake in another $9.3 billion. These revenues will be split with BioNTech, the German company that helped them develop the vaccine .

Although Moderna’s vaccine hasn't been globally approved for use yet, they are expecting to get the green signal by this Friday.

The Moderna vaccine is expected to rally about $10 billion and $15 billion across both 2021 and 2022, and another $2 billion to $3 billion in sales of additional booster shots

Pfizer decided to go all in , and their entire project is self funded, whereas Moderna decided to take advantage of the federal initiative project called Operation warp speed; to fund the development of COVID-19 vaccine in US.

But the journey isn't going to be that easy, apart from the fact that the developed “first world nations” are hoarding the vaccines, making it almost impossible for the developing “third world nations” to deal with the pamdemic. The vaccine is expensive and the refrigerated transportation, deep freeze storage and administration of the shots is not going to be a walk in the park, owing tho the special conditions in which the vaccine needs to be kept for maximum efficacy.

The transportation of the vaccine of being considered as one of the biggest challenges in the transportation industry by the cargo airline execs, and could potentially take unto 2 years for everyone on the planet to physically get the vaccine.

Hospitals in the US have rushed to buy the super-cold freezers to store Pfizer's vaccine to be kept at -94 degree Fahrenheit.

For lower-income countries experts, it may take unto 4 years to immunise majority of their population.

Reporting for EasyKobo on Monday ,14 December 2020 in Lagos, Nigeria